Cell Biology

A.C. Rapraeger, A. Krufka, B.B. Olwin, "Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation," Science, 252:1705, 1991. Alan Rapraeger (University of Wisconsin, Madison): "The gratifying aspect of this work has been its appeal to a wide group of scientists, owing to its relevance to cell-matrix interactions, cell growth and differentiation, and cell signaling mechanisms. The broad appeal of the work is partly because of the blending of my interests in

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A.C. Rapraeger, A. Krufka, B.B. Olwin, "Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation," Science, 252:1705, 1991.

Alan Rapraeger (University of Wisconsin, Madison): "The gratifying aspect of this work has been its appeal to a wide group of scientists, owing to its relevance to cell-matrix interactions, cell growth and differentiation, and cell signaling mechanisms. The broad appeal of the work is partly because of the blending of my interests in the role of syndecans in cell-matrix interactions with the interests of Brad Olwin, a coauthor on the paper also at UW-Madison, in FGF signaling during muscle differentiation.

"The fibroblast growth factors (FGFs) have been envisioned to signal via tyrosine-kinase receptors, and these receptors and their variants are now being described in detail. However, the affinity of these growth factors for heparan sulfate has suggested an important role for heparan sulfate-bearing proteoglycans in FGF signaling. These proteo-glycans, particularly ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies